SC Launch Inc. announces investment in NeuroQuest

SC Launch Inc., the investment affiliate of the South Carolina Research Authority, has invested $250,000 in NeuroQuest. The Charleston-based company is developing NeuroScreen® to provide an accurate and affordable blood test for early screening and monitoring of asymptomatic Alzheimer’s disease.

NeuroQuest became a SCRA Member Company and SC Launch Inc. Portfolio Company when it received its first investments totaling $550,000.

According to the Alzheimer’s Association, nearly 7 million Americans are living with Alzheimer’s disease, and by 2050, this number is projected to rise to almost 13 million. “These devastating statistics are why we’re so supportive of NeuroQuest’s mission,” said SC Launch Program Director Lee MacIlwinen. “NeuroQuest’s team is comprised of medical experts and business professionals from around the world with extensive experience in innovation, development, and clinical research, and they have the experience to lead in this ground-breaking way.”